Abstract
To determine the prevalence of parvovirus 4 infection and its clinical and sociodemographic correlations in Finland, we used virus-like particle-based serodiagnostic procedures (immunoglobulin [Ig] G, IgM, and IgG avidity) and PCR. We found 2 persons with parvovirus 4 primary infection who had mild or asymptomatic clinical features among hepatitis C virus-infected injection drug users.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Viral / blood*
-
DNA, Viral
-
Finland / epidemiology
-
HIV Infections / complications*
-
HIV Infections / epidemiology
-
Hepacivirus / genetics
-
Hepatitis C / complications*
-
Hepatitis C / epidemiology
-
Hepatitis C / virology
-
Humans
-
Immunoglobulin G / blood
-
Immunoglobulin M / blood
-
Parvoviridae Infections / diagnosis
-
Parvoviridae Infections / epidemiology*
-
Parvoviridae Infections / immunology
-
Parvoviridae Infections / virology
-
Parvovirus / genetics
-
Parvovirus / immunology*
-
Polymerase Chain Reaction
-
Prevalence
-
Serologic Tests / methods
-
Substance Abuse, Intravenous / complications*
-
Substance Abuse, Intravenous / epidemiology
Substances
-
Antibodies, Viral
-
DNA, Viral
-
Immunoglobulin G
-
Immunoglobulin M